Yatharth Hospital & Trauma Care Services Ltd
NSE:YATHARTH
Yatharth Hospital & Trauma Care Services Ltd
Yatharth Hospital & Trauma Care Services Ltd is a IN-based company operating in Health Care Providers & Services industry. The company is headquartered in Greater Noida, Uttar Pradesh. The company went IPO on 2023-08-07. Yatharth Hospital & Trauma Care Services Limited is engaged in the business of providing healthcare services, operating hospitals, and other allied services. The company offers facilities, such as amenities, guidelines for admission, visitor policy, helpdesk, and empanelment. The firm provides a spectrum of super specialty services in the field of cardiology, cardiovascular and thoracic surgery, neurology, neurosurgery, urology, nephrology, oncology, gastroenterology and surgical gastroenterology, orthopedics, including spine surgery, joint replacement, and sports medicine, plastic and reconstructive surgery, pulmonology, comprehensive mother and childcare including advanced in vitro fertilization. The firm also provides services, such as dermatology, ophthalmology, dentistry, psychology and psychiatry, anesthesiology, physiotherapy and rehab, radiology, pathology and laboratory medicine, and nutrition and health. The company has hospitals in Noida, Jhansi, Greater Noida, and Noida Extension.
Yatharth Hospital & Trauma Care Services Ltd is a IN-based company operating in Health Care Providers & Services industry. The company is headquartered in Greater Noida, Uttar Pradesh. The company went IPO on 2023-08-07. Yatharth Hospital & Trauma Care Services Limited is engaged in the business of providing healthcare services, operating hospitals, and other allied services. The company offers facilities, such as amenities, guidelines for admission, visitor policy, helpdesk, and empanelment. The firm provides a spectrum of super specialty services in the field of cardiology, cardiovascular and thoracic surgery, neurology, neurosurgery, urology, nephrology, oncology, gastroenterology and surgical gastroenterology, orthopedics, including spine surgery, joint replacement, and sports medicine, plastic and reconstructive surgery, pulmonology, comprehensive mother and childcare including advanced in vitro fertilization. The firm also provides services, such as dermatology, ophthalmology, dentistry, psychology and psychiatry, anesthesiology, physiotherapy and rehab, radiology, pathology and laboratory medicine, and nutrition and health. The company has hospitals in Noida, Jhansi, Greater Noida, and Noida Extension.
Record Revenue: Yatharth Hospitals delivered its highest-ever quarterly revenue of INR 3,205 million in Q3 FY26, up 46% year-on-year and 15% quarter-on-quarter.
Profitability Growth: Net profit rose 41% year-on-year to INR 431 million, and EBITDA reached an all-time high of INR 742 million, up 35% year-on-year.
New Hospitals Scale Up: Newly opened New Delhi and Faridabad Sector 20 hospitals contributed INR 279 million (9% of group revenue), with strong ARPOB and high cash/private insurance mix.
Operational Metrics: Network occupancy was healthy at 67%, with flagship hospitals like Noida hitting 91% occupancy and Noida Extension achieving a record ARPOB of INR 44,000.
Margin Outlook: Adjusted EBITDA margin stood at 29.2%. Management guided for 24-25% consolidated EBITDA margin as network grows, reflecting drag from new hospitals.
Expansion Plans: The company targets increasing capacity to 5,000 beds over 3 years with a total CapEx of INR 1,500 crores, using a mix of brownfield, greenfield, and asset-light expansions focused on NCR and North India.
Payer Mix Shift: Current government business mix (~35%) is set to decline below 30% over 2 years as cash and TPA insurance rise, targeting improved receivable days.
ARPOB & Oncology: Group ARPOB increased 10% YoY to INR 33,744. Oncology revenues saw a significant jump and are expected to reach 15% of specialty revenue in under two years.
